Integra LifeSciences Holdings Corporation
IART
$13.01
$0.090.70%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 382.65M | 442.65M | 380.83M | 418.18M | 368.87M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 382.65M | 442.65M | 380.83M | 418.18M | 368.87M |
| Cost of Revenue | 167.51M | 176.80M | 162.79M | 167.39M | 149.02M |
| Gross Profit | 215.15M | 265.84M | 218.04M | 250.78M | 219.86M |
| SG&A Expenses | 159.55M | 172.92M | 164.94M | 175.72M | 155.19M |
| Depreciation & Amortization | 3.70M | 3.72M | 3.76M | 3.71M | 3.04M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 351.17M | 378.33M | 355.71M | 371.00M | 328.37M |
| Operating Income | 31.48M | 64.32M | 25.13M | 47.17M | 40.50M |
| Income Before Tax | -30.04M | 22.54M | -20.36M | -15.19M | -5.23M |
| Income Tax Expenses | -4.74M | 3.11M | -9.67M | -2.78M | -1.95M |
| Earnings from Continuing Operations | -25.29M | 19.44M | -10.70M | -12.40M | -3.28M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.29M | 19.44M | -10.70M | -12.40M | -3.28M |
| EBIT | 31.48M | 64.32M | 25.13M | 47.17M | 40.50M |
| EBITDA | 68.67M | 109.01M | 46.89M | 91.05M | 71.07M |
| EPS Basic | -0.33 | 0.25 | -0.14 | -0.16 | -0.04 |
| Normalized Basic EPS | 0.15 | 0.40 | 0.11 | 0.29 | 0.26 |
| EPS Diluted | -0.33 | 0.25 | -0.14 | -0.16 | -0.04 |
| Normalized Diluted EPS | 0.15 | 0.40 | 0.11 | 0.29 | 0.26 |
| Average Basic Shares Outstanding | 76.46M | 76.42M | 76.45M | 77.41M | 77.74M |
| Average Diluted Shares Outstanding | 76.46M | 76.42M | 76.45M | 77.41M | 77.74M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |